Shannon M. May

Learn More
The distribution of viruses and gene therapy vectors is difficult to assess in a living organism. For instance, trafficking in murine models can usually only be assessed after sacrificing the animal for tissue sectioning or extraction. These assays are laborious requiring whole animal sectioning to ascertain tissue localization. They also obviate the(More)
In this article, I examine HP's e-Inclusion program and its implementation in In-dia to show how the high-tech industry's efforts to alleviate poverty proªtably are guided by C. K. Prahalad's ideas about the Bottom of the Pyramid (BoP), and are framed as digital corporate citizenship activities. While the BoP highlights the importance of new markets for(More)
Although there are 55 serotypes of adenovirus (Ad) that infect humans, Ad serotype 5 (Ad5) is the most widely studied because of the availability of commercial kits for its genetic manipulation. In fact, engineered Ad 5 is currently being used in all of the 87 global clinical trials utilizing Ad for the treatment of cancer. Unfortunately, Ad5 is one of the(More)
In response to many scientific discoveries linking cancer in certain families to inherited factors, the Vermont Cancer Center established the Familial Cancer Program (FCP) in December 1993. This multifaceted program combines the expertise of clinicians and researchers in many disciplines, including genetics, oncology, psychology, and molecular biology. The(More)
  • 1